Safety Intravenous Indwelling Needle Market Report：the global market size is projected to grow from USD 768.33 million in 2023 to USD 1069.47 million by 2029

Safety intravenous indwelling needle is a medical device used for intravenous infusion treatment. It is designed with special safety protection measures to reduce the risk of needle stick injuries to medical staff during operation and improve patient safety during use.

 

According to the new market research report "Safety Intravenous Indwelling Needle - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030", published by QYResearch, the global Safety Intravenous Indwelling Needle market size is projected to grow from USD 768.33 million in 2023 to USD 1069.47 million by 2029, at a CAGR of 5.67% during the forecast period.

• Global Safety Intravenous Indwelling Needle MarketSize(US$ Million), 2023-2029

 

Source: QYResearch, "Safety Intravenous Indwelling Needle - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030”

 

 

• Global Safety Intravenous Indwelling Needle Top10Players Ranking and Market Share (Ranking is based on the revenue of 2022, continually updated)

 

Source: QYResearch, "Safety Intravenous Indwelling Needle - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030”

 

This report profiles key players of Safety Intravenous Indwelling Needle such as BD，B. Braun Medical Inc.，Medikit，Daikin，Smiths Medica

In 2022, the global top five Safety Intravenous Indwelling Needle players account for 21.33% of market share in terms of revenue. Above figure shows the key players ranked by revenue in Safety Intravenous Indwelling Needle.

Market Drivers:

1. Improved patient experience: Safe intravenous indwelling needles can reduce the pain of repeated punctures and improve patient comfort, thereby improving patient satisfaction and compliance.
2. Hospital infection control: Because safe intravenous indwelling needles can reduce the number of punctures and reduce the risk of cross-infection, they comply with hospital infection control policies and high standards.
3. Promotion of policies and regulations: Strict regulations and standards on medical safety by governments and medical institutions, as well as regulatory requirements on the quality and safety of medical devices, have strongly promoted the use of safe intravenous indwelling needles.
4. Technological innovation and market competition: Medical equipment manufacturers continue to develop new products and improve the convenience, safety and effectiveness of indwelling needles through technological innovation to meet market demand and improve competitiveness.

Restraint:

1. Cost factors: Compared with traditional intravenous indwelling needles, safety products may increase in cost due to additional safety design and process technology. For cost-sensitive medical institutions, this may affect their purchasing willingness.
2. Technical and operational training: The introduction of new products requires additional technical training for medical staff, and some medical institutions may hesitate due to factors such as training costs and staff mobility.
3. Product reliability and adaptability: Although safe intravenous catheters have many advantages in theory, in actual use, they may encounter applicability problems caused by differences in patient physiques, vascular conditions, and operating techniques, which require continuous improvement of the product.
4. Market awareness and acceptance: Some medical institutions or medical staff may have a conservative attitude towards the performance and effects of new products, and it will take some time to become familiar with and accept them.
5. Healthcare system resource allocation: In healthcare systems with limited resources, limited budget allocation and procurement strategies may cause hospitals to prioritize more basic medical needs rather than immediately updating to the latest generation of safe intravenous catheters.

 

About The Authors

Yaping Zhao - Lead Author

Email: zhaoyaping@qyresearch.com

About QYResearch

QYResearch founded in California, USA in 2007.It is a leading global market research and consulting company. With over 16 years’ experience and professional research team in various cities over the world QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 60,000 clients across five continents. Let’s work closely with you and build a bold and better future.

QYResearch is a world-renowned large-scale consulting company. The industry covers various high-tech industry chain market segments, spanning the semiconductor industry chain (semiconductor equipment and parts, semiconductor materials, ICs, Foundry, packaging and testing, discrete devices, sensors, optoelectronic devices), photovoltaic industry chain (equipment, cells, modules, auxiliary material brackets, inverters, power station terminals), new energy automobile industry chain (batteries and materials, auto parts, batteries, motors, electronic control, automotive semiconductors, etc.), communication industry chain (communication system equipment, terminal equipment, electronic components, RF front-end, optical modules, 4G/5G/6G, broadband, IoT, digital economy, AI), advanced materials industry Chain (metal materials, polymer materials, ceramic materials, nano materials, etc.), machinery manufacturing industry chain (CNC machine tools, construction machinery, electrical machinery, 3C automation, industrial robots, lasers, industrial control, drones), food, beverages and pharmaceuticals, medical equipment, agriculture, etc.

 

Contact Us:

If you have any queries regarding this report or if you would like further information, please contact us:

QY Research Inc.

Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States

E-mail: global@qyresearch.com

Tel: 001-626-842-1666(US)  0086-133 1872 9947(CN)

EN: https://www.qyresearch.com

JP: https://www.qyresearch.co.jp